ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics
ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics have?
ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics has 114 citations in the OpenAlex counts ScholarIQ stores.
When was ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics published?
ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics has 2019 year in the ScholarIQ index.
What is the open-access status of ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics?
ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics has closed oa status in the ScholarIQ index.
What is the DOI of ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics?
The DOI for ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics is on the source record.
What is the PMID of ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics?
The PMID for ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics is on the source record.
What is the OpenAlex record for ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics?
The OpenAlex for ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics is on the source record.